A phase I/II study of the safety, pharmacokinetic interaction and efficacy of S-3304 in combination with standard therapy in patients with locally advanced non-small cell lung cancer.
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 17 Sep 2005
At a glance
- Drugs S 3304 (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 17 Sep 2005 New trial record.